|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/22 | |
| A61K 9/52 |
| (11) | Patento numeris | 2552423 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11763349.5 |
| Europos patento paraiškos padavimo data | 2011-03-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-02-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-07-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/030444 |
| Data | 2011-03-30 |
| (87) | Numeris | WO 2011/123497 |
| Data | 2011-10-06 |
| (30) | Numeris | Data | Šalis |
| 282787 P | 2010-03-31 | US |
| (72) |
CHANG, Rong-Kun, US
VIEIRA, Michael, L., US
LIANG, Likan, US
BHATT, Padmanabh, P., US
HUANG, Austin, B., US
PATEL, Sachin, V., US
|
| (73) |
Supernus Pharmaceuticals, Inc.,
1550 East Gude Drive, Rockville, MD 20850,
US
|
| (54) | STABILIZED FORMULATIONS OF CNS COMPOUNDS |
| STABILIZED FORMULATIONS OF CNS COMPOUNDS |